Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure

doi:10.4330/wjc.v16.i11.619

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (864)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

487

Figures (1-1)

Tables (1-1)

Sum=649

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=114

Publishing Process of This Article

Item

Count

Browse

Download

Sum=70

Nov 26, 2024 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Cardiol. Nov 26, 2024; 16(11): 619-625
Published online Nov 26, 2024. doi: 10.4330/wjc.v16.i11.619

Open in New Tab Full Size Figure Download Figure

Figure 1 Different sources for mesenchymal stem cell. MSCs: Mesenchymal stem cells.

Citation: Shah S, Nawaz HS, Qazi MS, Jain H, Lucke-Wold B. Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure. World J Cardiol 2024; 16(11): 619-625
URL: https://www.wjgnet.com/1949-8462/full/v16/i11/619.htm
DOI: https://dx.doi.org/10.4330/wjc.v16.i11.619